Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Poolbeg Pharma Ltd. ( (GB:POLB) ).
Poolbeg Pharma Ltd. and HOOKIPA Pharma Inc. are exploring a potential combination, with major shareholder Gilead Sciences Inc. signaling its support if a formal offer is made. HOOKIPA plans a $30 million private placement fundraise, highlighting continued interest and investment in their collaboration, although no firm offer has been finalized.
More about Poolbeg Pharma Ltd.
Poolbeg Pharma Ltd. operates in the pharmaceutical industry, with a focus on developing medicines for infectious diseases and other unmet medical needs. They are engaged in research and development, aiming to bring innovative treatments to the market.
YTD Price Performance: -40.85%
Average Trading Volume: 1,632,438
Technical Sentiment Consensus Rating: Buy
Find detailed analytics on POLB stock on TipRanks’ Stock Analysis page.
